To link to this article, copy this persistent link:
(Oct 05, 2012) On August 13, 2012,
According to the Provisions, the SFDA and its provincial-level counterparts will publish drug safety blacklists on their official websites. The blacklists are to contain information on pharmaceutical manufacturing and trading companies on which administrative penalties have been imposed due to their serious violation of laws and regulations regarding medicine and medical devices, as well as information on their directly responsible personnel. (
The Provisions specify the circumstances under which a violator will be added to the blacklist, including:
1. having had a certificate or licenses for the manufacture or trade in medicine or medical devices revoked due to manufacturing or distributing counterfeit drugs or sub-standard drugs or medical devices or manufacturing medical devices without a license;
2. concealing relevant information or providing false materials when applying for relevant administrative permits; or
3. providing false documents, cheating, or giving bribes to obtain relevant administrative permits. (
art. 7.) Id.
The SFDA and its provincial-level counterparts will add the information about a violator to their respective blacklists within 15 days of the date on which an administrative penalty decision takes effect. (
|Author:||Laney Zhang More by this author|
|Topic:||Health and safety More on this topic|
|Jurisdiction:||China More about this jurisdiction|
Search Legal News
Find legal news by topic, country, keyword, date, or author.
Global Legal Monitor RSS
Get the Global Legal Monitor delivered to your inbox. Sign up for RSS service.
The Global Legal Monitor is an online publication from the Law Library of Congress covering legal news and developments worldwide. It is updated frequently and draws on information from the Global Legal Information Network, official national legal publications, and reliable press sources. You can find previous news by searching the GLM.
Last updated: 10/05/2012